OR5AO1P

Across TCGA pan-cancer cohorts, OR5AO1P RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated OR5AO1P data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher OR5AO1P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR5AO1P expression acts as an unfavorable survival marker, although some lineages such as BRCA and LUAD show a favorable association.

READ, COAD, and LUSC are the cancer types where OR5AO1P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Tertile	All	0.171	0.673	<.001	153	view →
COAD	OS	Tertile	All	0.250	0.701	.001	75	view →
LUSC	DFS	Tertile	III,IV	0.184	0.581	<.001	69	view →
ACC	DFS	Tertile	III,IV	0.010	0.458	<.001	63	view →
OV	OS	Tertile	II,III,IV	0.696	0.846	.011	54	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
SKCM	DFS	Tertile	IV	0.044	0.477	.004	18	view →
DLBC	OS	Tertile	II,III,IV	0.118	0.802	.025	18	view →
BRCA	DFS	Tertile	III,IV	0.900	0.773	.036	18	view →
KIRP	DFS	Tertile	All	0.326	0.809	.010	18	view →
LAML	DFS	Tertile	All	0.111	0.571	.018	18	view →
LUAD	OS	Tertile	All	0.551	0.297	.027	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

OR5AO1P–READ (OS)

Open the READ breakdown →